George Calin: AI and RNA Therapeutics New Directions in Precision Oncology
George Calin/Linkedin

George Calin: AI and RNA Therapeutics New Directions in Precision Oncology

George Calin, Professor at MD Anderson Cancer Center, shared on LinkedIn:

“Thank you to Will Symmans, Ziyi Li and Sam Akanksha for the excellent review just published in Cell Reports Medicine on ‘AI-integrated RNA therapeutics in precision oncology’.

All three are young and bright and love science!

We evaluated AI across the RNA therapeutic development pipeline, distinguished evidence-supported applications from preclinical and speculative uses, and discussed the validation, regulatory, and data-governance requirements for translation into precision oncology.

Enjoy reading and ENJPY Science!”

Title: AI-integrated RNA therapeutics in precision oncology

Authors: William S.O. Symmans, Ziyi Li, George A. Calin, Akanksha Samuel

Read the full article. 

You can also read:

Brian Grieb at COGC 2026: How Fast Can Testing Really Be? A Powerful Look at Rapid Precision Oncology

George Calin: AI and RNA Therapeutics New Directions in Precision Oncology